{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# **GPT4ALL QA from docs:**\n",
    "**Para analizar grandes cantidades de datos el precio de OpenAI deja de ser trivial, por lo tanto se explora la posibilidad de usar modelos en local que realicen lo mismo pero con el nivel más parecido al SotA actual.\n",
    "Es por esto que se intenta usar [GPT4ALL](https://github.com/nomic-ai/gpt4all) y su implementación mediante librería [Langchain](https://python.langchain.com/en/latest/index.html#)**\n",
    "\n",
    "**Sin embargo, los embeddings de OPENAI siguen siendo baratos y efectivos, por lo que su uso sí tiene sentido**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Imports and setup\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import csv\n",
    "import os\n",
    "import re\n",
    "import io\n",
    "import json\n",
    "import pypdf\n",
    "import langchain\n",
    "from langchain.document_loaders.csv_loader import CSVLoader\n",
    "from langchain.indexes import VectorstoreIndexCreator\n",
    "import pyllamacpp\n",
    "import tabula\n",
    "import openai\n",
    "\n",
    "api_key = json.load(open('./data/creds/gpt_id.json'))['api_key']\n",
    "openai.api_key = api_key\n",
    "os.environ['OPENAI_API_KEY'] = api_key"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Funciones esenciales de procesamiento:\n",
    "def limpieza_texto(texto: str) -> str:\n",
    "    '''\n",
    "    Función para limpiar texto de pdfs.\n",
    "    Cambia saltos de línea, espacios en blanco y caracteres especiales.\n",
    "    '''\n",
    "    # Eliminamos espacios en blanco\n",
    "    #texto = re.sub(' +', ' ', texto)\n",
    "    # Eliminamos caracteres especiales [REVISAR]\n",
    "    #texto = re.sub('[^A-Za-z0-9]+', ' ', texto)\n",
    "    # Eliminamos saltos múltiples de línea\n",
    "    texto = re.sub(r\"\\n\\s*\\n\", \"\\n\\n\", texto)\n",
    "    texto = re.sub(r\"\\n\", \";\", texto)\n",
    "    return texto\n",
    "\n",
    "def tabla_a_texto(tabla):\n",
    "    '''\n",
    "    Función para convertir una tabla de pandas en un texto.\n",
    "    La idea es identificar los nombres de columna e índices correctos y\n",
    "    a partir de ahí generar un texto que pueda ser procesado por el modelo.\n",
    "    '''\n",
    "    tabla = tabla.copy()\n",
    "    \n",
    "    # Tamaño mínimo de tabla para que sea válida = 2x2\n",
    "    if sum(tabla.shape) < 4:\n",
    "        return ''\n",
    "    \n",
    "    # Lista de valores que consideramos NaN:\n",
    "    nan_equivalents = [np.NaN, np.nan,\n",
    "                       'nan', 'NaN', 'Nan', 'NAN', 'na', 'NA',\n",
    "                       'Unnamed:0', 'Unnamed: 0'\n",
    "                       '', '-', ' ', '  ', '   ']\n",
    "    \n",
    "    # Asumimos que el primer elemento es el título salvo si es NaN:\n",
    "    titulo = tabla.columns[0] if tabla.columns[0] not in nan_equivalents else ''\n",
    "    \n",
    "    # Asumimos que la primera columna es el índice y la eliminamos:\n",
    "    tabla.index = tabla[tabla.columns[0]].values\n",
    "    tabla.drop(columns=tabla.columns[0], inplace=True)\n",
    "\n",
    "    # Si las columnas tienen muchos 'Unnamed' suele ser porque hay\n",
    "    # varias líneas de texto. En ese caso, las juntamos en una sola:\n",
    "    if sum(['Unnamed' in i for i in tabla.columns]) > 2:\n",
    "        nueva_columna = [f'{tabla.columns[i]} {tabla.iloc[0,i]}'\n",
    "                         for i in range(len(tabla.columns))]\n",
    "        nueva_columna = [i.replace('Unnamed: ','') for i in nueva_columna]\n",
    "        tabla.columns = nueva_columna\n",
    "\n",
    "    \n",
    "    # Eliminamos las filas y columnas que no tienen datos:\n",
    "    tabla.replace(nan_equivalents, np.nan, inplace=True)\n",
    "    tabla.dropna(axis=0, how='all', inplace=True)\n",
    "    tabla.dropna(axis=1, how='all', inplace=True)\n",
    "    \n",
    "    # Check si las columnas son años:\n",
    "    col_años = False\n",
    "    years_txt=[str(i) for i in range(2015,2022)]\n",
    "    years_int=[i for i in range(2015,2022)]\n",
    "    years = set(years_txt+years_int)\n",
    "    cruce = set(tabla.columns).intersection(set(years))\n",
    "    if len(cruce) > 0: col_años=True\n",
    "    \n",
    "    # Si no son años las columnas, buscamos filas que sean años:\n",
    "    contexto = None\n",
    "    if not col_años:\n",
    "        for i in tabla.iterrows():\n",
    "            #print(i[1].values)\n",
    "            try:\n",
    "                cruce = set(i[1].values).intersection(set(years))\n",
    "            except:\n",
    "                cruce=[]\n",
    "            if len(cruce)>0: # Si encontramos una fila con años:\n",
    "                # Asignamos los años a las columnas:\n",
    "                tabla.columns = i[1].values\n",
    "                try: \n",
    "                    contexto = i[1].name\n",
    "                except:\n",
    "                    contexto = None\n",
    "                # Drop de la fila:\n",
    "                tabla.drop(i[0], inplace=True)\n",
    "                break\n",
    "    # Los procesos anteriores pueden haber dejado filas vacías, las eliminamos:\n",
    "    tabla.replace(nan_equivalents, np.nan, inplace=True)\n",
    "    tabla.dropna(axis=0, how='all', inplace=True)\n",
    "    tabla.dropna(axis=1, how='all', inplace=True)\n",
    "    # Pasamos a texto:\n",
    "    texto = ''\n",
    "    for i in tabla.items():\n",
    "        txt = [f' {titulo} + {i[0]} + {x[0]} = {x[1]}; '\n",
    "            for x in list(i[1].items())]\n",
    "        add= ''.join(txt)\n",
    "        if contexto:\n",
    "            txt = [f' {titulo} + {contexto} + {i[0]} + {x[0]} = {x[1]}; '\n",
    "                for x in list(i[1].items())]\n",
    "            add = ''.join(txt)\n",
    "        add = add.replace('  ',' ').replace('\\n','; ').replace('  ','')\n",
    "        texto += f';  Tabla={titulo}: {add}'\n",
    "    return texto\n",
    "\n",
    "def extract_text_from_pdf(pdf_path: str) -> list:\n",
    "    '''\n",
    "    Función para extraer texto de un pdf y limpiarlo.\n",
    "    Devuelve una lista de str, cada una es una página del pdf.\n",
    "    '''\n",
    "    # Abrimos el pdf\n",
    "    with open(pdf_path, 'rb') as f:\n",
    "        pdf = pypdf.PdfReader(f)\n",
    "        # Obtenemos el número de páginas\n",
    "        num_pags = len(pdf.pages)\n",
    "        count = 0\n",
    "        text = []\n",
    "        # Iteramos sobre las páginas\n",
    "        for pag in pdf.pages:\n",
    "            count +=1\n",
    "            texto_pagina = pag.extract_text()\n",
    "            tablas = tabula.read_pdf(pdf_path, pages=count)\n",
    "            for tabla in tablas:\n",
    "                texto_pagina += f'; {tabla_a_texto(tabla=tabla)}; '\n",
    "            texto_pagina = limpieza_texto(texto_pagina)\n",
    "            text.append(texto_pagina)\n",
    "    return text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Preprocesado de un PDF de ejemplo para probar el modelo:\n",
    "# Test con un pdf\n",
    "resultado = extract_text_from_pdf('./data/rovi-sostenibilidad-2020.pdf')\n",
    "\n",
    "# Guardamos el resultado en un csv con 1 fila por página\n",
    "with open('lista_test_2.csv', 'w', newline='') as file:\n",
    "    \n",
    "    writer = csv.writer(file)\n",
    "    writer.writerows([[str(i)] for i in resultado])\n",
    "\n",
    "splitter = langchain.text_splitter.RecursiveCharacterTextSplitter(\n",
    "    chunk_size=500,\n",
    "    chunk_overlap=50,\n",
    "    length_function = len)\n",
    "\n",
    "x = splitter.create_documents(resultado, metadatas=[{'source': f'lista_test_2.csv pag{i}'} for i in list(range(len(resultado)))])\n",
    "\n",
    "loader = CSVLoader(file_path='lista_test_2.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "documentos = loader.load()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [],
   "source": [
    "# GPT4All CHAIN for QA:\n",
    "gpt4all_path = './data/models/gpt4all-7B/gpt4all-lora-quantized_new.bin'\n",
    "llm = langchain.llms.gpt4all.GPT4All(model=gpt4all_path,\n",
    "                                     n_threads=12)\n",
    "opai_llm = langchain.llms.openai.OpenAI()\n",
    "embedding = langchain.embeddings.openai.OpenAIEmbeddings()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[2023-04-06 14:40:15,657] {posthog.py:15} INFO - Anonymized telemetry enabled. See https://docs.trychroma.com/telemetry for more information.\n",
      "[2023-04-06 14:40:15,658] {__init__.py:79} INFO - Running Chroma using direct local API.\n",
      "[2023-04-06 14:40:15,659] {__init__.py:48} WARNING - Using embedded DuckDB without persistence: data will be transient\n"
     ]
    }
   ],
   "source": [
    "vector_store = langchain.vectorstores.Chroma.from_documents(documentos, embedding)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [],
   "source": [
    "recuperador = vector_store.as_retriever()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [],
   "source": [
    "cadena = langchain.chains.question_answering.load_qa_chain(llm=opai_llm)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Document(page_content='REPORT;20;20: –Profarma;Each year, in the Plan Profarma, the Ministry of Industry, Tourism and Trade and the Ministry ;of Health, Social Services and Equality classify the pharmaceutical Companies in accordance ;with their contribution to the Spanish industrial fabric, taking their investment in technology, ;new manufacturing plants, research efforts, etc. as a reference. In February 2020, the results ;of Plan Profarma 2019 were issued and ROVI obtained the classification of Excellent for the ;fourteenth consecutive year. ;KEY FIGURES;(million euros) 2020 2019 2018 2017;Total revenue 421.1 382.5  304.8 277.4;EBITDA 94.2 60.9 29.5 29.9;Net financial debt 19.8 15.9 -62.8 1.1;Employees 1.419 1.310 1.224 1.191102-7;14; ;  Tabla=KEY FIGURES:  KEY FIGURES + (million euros) + 2020.0 + Total revenue = 421.1; KEY FIGURES + (million euros) + 2020.0 + EBITDA = 94.2; KEY FIGURES + (million euros) + 2020.0 + Net financial debt = 19.8; KEY FIGURES + (million euros) + 2020.0 + Employees = 1.419; ;  Tabla=KEY FIGURES:  KEY FIGURES + (million euros) + 2019.0 + Total revenue = 382.5; KEY FIGURES + (million euros) + 2019.0 + EBITDA = 60.9; KEY FIGURES + (million euros) + 2019.0 + Net financial debt = 15.9; KEY FIGURES + (million euros) + 2019.0 + Employees = 1.31; ;  Tabla=KEY FIGURES:  KEY FIGURES + (million euros) + 2018.0 + Total revenue = 304.8; KEY FIGURES + (million euros) + 2018.0 + EBITDA = 29.5; KEY FIGURES + (million euros) + 2018.0 + Net financial debt = -62.8; KEY FIGURES + (million euros) + 2018.0 + Employees = 1.224; ;  Tabla=KEY FIGURES:  KEY FIGURES + (million euros) + 2017.0 + Total revenue = 277.4; KEY FIGURES + (million euros) + 2017.0 + EBITDA = 29.9; KEY FIGURES + (million euros) + 2017.0 + Net financial debt = 1.1; KEY FIGURES + (million euros) + 2017.0 + Employees = 1.191; ;', metadata={'source': 'lista_test_2.csv', 'row': 12}), Document(page_content='REPORT;20;20: 3.2. BALANCE OF THE YEAR AND FUTURE CHALLENGES;Although 2020 was an unexpectedly complicated year, it had new opportunities that ;ROVI had been preparing to take advantage of, due to factors such as the marketing of an ;enoxaparin biosimilar, the development of drugs with prospects of being widely used to treat ;complaints, the development of operating synergies and the extension of the scope of the ;value-added manufacturing services with current and potential customers; the launch of ;new products in the market and, particularly in 2020, the manufacturing agreement signed ;with Moderna to provide filling and packaging capacity for hundreds of millions of doses ;of its candidate vaccine outside the United States, acquiring a new production line and ;equipment for compounding, filling, automatic visual inspection and labelling.;Overall, all the foregoing led to an improvement in the company’s financial results: operating ;revenue rose by 10% to 420 million euros (increase of 6.5 percentage points in the EBITDA ;margin to 22.4%) and ROVI’s net profit increased by 55%, to 61.1 million euros.;By business line, prescription pharmaceutical sales rose by 6% to 297 million euros, showing ;growth 4 percentage points higher than the Spanish market in 2020, which, according to the ;consultant IQVIA, rose by 2%. ;The most outstanding products were Neparvis®, indicated for the treatment of adult ;patients with symptomatic chronic heart failure with reduced ejection  fraction, sales of ;which increased to 29.6 million euros, 34% up on 2019; and Volutsa®, a prescription product ;belonging to the company Astellas Pharma and distributed by ROVI, indicated for the ;treatment of moderate to severe storage and voiding symptoms associated with benign ;prostatic hyperplasia, which obtained a sales increase of 7%, rising to 14.2 million euros.;Heparin division sales (low-molecular-weight heparins (LMWH) and other heparins) rose by ;14% to 209.3 million euros. Sales of these products accounted for 50% of operating revenue ;in 2020, 2% higher than in 2019. Low-molecular-weight heparin (LMWH) sales increased by ;14% to 202.8 million euros. Specifically, the enoxaparin biosimilar showed a 25% sales increase, ;rising to 101.4 million euros, and bemiparin sales increased by 5%, also to 101.4 million euros.;In the case of bemiparin, the significant increase in international sales should be highlighted. ;They now represent 33%, due to the increase in transfer prices to some partners as a result ;of the increase in the price of the raw material. For 2021, international sales of bemiparin are ;expected to rise by a high-teen figure.;Lastly, toll manufacturing sales rose by 39% in comparison with the preceding year, ;totalling 91.6 million euros, mainly due to the redirection of the strategy for the activities of ;this business line towards products with higher value-added, where the agreement with ;Moderna for the manufacture of the large scale fill-finish of its candidate mRNA vaccine ;against COVID-19 (mRNA-1273) at ROVI’s Madrid facility was one of the year’s great milestones.;As part of the agreement, ROVI will provide fill-finish capacity for vials by acquiring a new ;production line and equipment for compounding, filling, automatic visual inspection and ;labelling, in order to provide support to the candidate vaccine, with which it was, in principle, ;planned to supply markets outside the United States as of the beginning of 2021, hiring the ;necessary additional personnel for the manufacturing and production operations.;39', metadata={'source': 'lista_test_2.csv', 'row': 37}), Document(page_content='REPORT;20;20: 3. CUSTOMERS, ;PATIENTS AND ;PROFESSIONALS;36', metadata={'source': 'lista_test_2.csv', 'row': 34}), Document(page_content='REPORT;20;20: 3.3. INNOVATION;ROVI continued with its constant involvement in medical research in 2020, allocating a ;significant part of its resources to work of this kind. Research & Development (R&D) expenses ;were 23.8 million euros. These R&D expenses were mainly related to carrying out the activities ;necessary to prepare the dossier of Doria® to be filed with the United States authority, the ;U.S. Food and Drug Administration (FDA); the development of Phase I of Letrozole-ISM® ; and ;the development of the new formulation of Risperidone-ISM® to be administered every three ;months.;At the same time, the company remains firm in its support of collaborative research ;through co-operation agreements with other leading benchmark companies in the sector, ;biotechnological companies, universities and public research centres, in order  to combine ;efforts, which results in an increase in scientific, technological, educational and knowledge-;sharing activities. This is a need and requirement of the “knowledge society” and, even at ;times when the economic circumstances are especially difficult, it is necessary to prioritise ;research and development in order to provide an answer to the great challenges in the health ;area and create a dynamic ecosystem of knowledge excellence at national, inter-institutional ;and multidisciplinary levels.;As a result of this commitment, as an agent at the service of society’s needs for the ;prevention and knowledge of certain diseases, in order to improve the health and quality ;of life of patients, ROVI placed its innovation capabilities at the service of the fight against ;COVID-19 in 2020. In this respect, it reached a collaboration agreement with the HM ;Hospitales group to fund a clinical trial that analyses the efficacy and safety of bemiparin ;patients who are in hospital with pneumonia due to COVID-19 and D-dimer higher than 500 ;ng/m, as well as another collaboration agreement with the University of Navarra to carry out ;the randomised, open-label clinical trial to evaluate the effect of prophylactic or therapeutic ;doses of bemiparin in patients with COVID-19 (BEMICOP).;Therefore, this study focuses on an exploratory analysis and evaluation of the safety and ;efficacy of the use of bemiparin, hoping for the results to provide sufficient clinical evidence ;to improve the selection of patients who can receive antithrombotic therapies to improve ;their prognosis and reduce the mortality associated to COVID-19. ;SOLID PATENT PORTFOLIO;At 31 December, 2020, ROVI had an invention portfolio composed of more than 613 dossiers, ;452 of which related to granted patent applications, while 161 were in the examination and ;evaluation phase. The developments of ROVI’s research are addressed mainly at three areas:;• Drug release technologies;• Glycomics;• Multi-layer technologies for use in urethral catheters.;The portfolio of products that the company has under development is mainly focused ;on heparin derivatives and other glycosaminoglycans, as well as the development of new ;controlled-release systems based on the ISM® technology patented by ROVI. This technology is ;intended to obtain new pharmaceutical products that replace the administration of drugs that ;require daily doses in chronic or prolonged treatments, as many be the case of pathologies like ;schizophrenia or certain types of cancer, by controlled-administration systems.;41', metadata={'source': 'lista_test_2.csv', 'row': 39})]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "' Yes, this report is about pharmaceuticals.'"
      ]
     },
     "execution_count": 82,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pregunta = 'is this report about pharmaceuticals?'\n",
    "similares = vector_store.similarity_search(pregunta, include_metadata=True, top_k=5)\n",
    "print(similares)\n",
    "cadena.run(input_documents = similares, question = pregunta)  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(page_content='REPORT;20;20: 98www.rovi.es', metadata={'source': 'lista_test_2.csv', 'row': 96}),\n",
       " Document(page_content='REPORT;20;20: SHAREHOLDER COMPOSITION;63.11%;Norbel Inversores, S.L.;5.57%;Indumenta Pueri, S.L.;3.043%;T.Rowe Price International Funds, Inc;3.005%;Wellington Management Group, LLP;25.275%;Other;7', metadata={'source': 'lista_test_2.csv', 'row': 5}),\n",
       " Document(page_content='REPORT;20;20: –Profarma;Each year, in the Plan Profarma, the Ministry of Industry, Tourism and Trade and the Ministry ;of Health, Social Services and Equality classify the pharmaceutical Companies in accordance ;with their contribution to the Spanish industrial fabric, taking their investment in technology, ;new manufacturing plants, research efforts, etc. as a reference. In February 2020, the results ;of Plan Profarma 2019 were issued and ROVI obtained the classification of Excellent for the ;fourteenth consecutive year. ;KEY FIGURES;(million euros) 2020 2019 2018 2017;Total revenue 421.1 382.5  304.8 277.4;EBITDA 94.2 60.9 29.5 29.9;Net financial debt 19.8 15.9 -62.8 1.1;Employees 1.419 1.310 1.224 1.191102-7;14; ;  Tabla=KEY FIGURES:  KEY FIGURES + (million euros) + 2020.0 + Total revenue = 421.1; KEY FIGURES + (million euros) + 2020.0 + EBITDA = 94.2; KEY FIGURES + (million euros) + 2020.0 + Net financial debt = 19.8; KEY FIGURES + (million euros) + 2020.0 + Employees = 1.419; ;  Tabla=KEY FIGURES:  KEY FIGURES + (million euros) + 2019.0 + Total revenue = 382.5; KEY FIGURES + (million euros) + 2019.0 + EBITDA = 60.9; KEY FIGURES + (million euros) + 2019.0 + Net financial debt = 15.9; KEY FIGURES + (million euros) + 2019.0 + Employees = 1.31; ;  Tabla=KEY FIGURES:  KEY FIGURES + (million euros) + 2018.0 + Total revenue = 304.8; KEY FIGURES + (million euros) + 2018.0 + EBITDA = 29.5; KEY FIGURES + (million euros) + 2018.0 + Net financial debt = -62.8; KEY FIGURES + (million euros) + 2018.0 + Employees = 1.224; ;  Tabla=KEY FIGURES:  KEY FIGURES + (million euros) + 2017.0 + Total revenue = 277.4; KEY FIGURES + (million euros) + 2017.0 + EBITDA = 29.9; KEY FIGURES + (million euros) + 2017.0 + Net financial debt = 1.1; KEY FIGURES + (million euros) + 2017.0 + Employees = 1.191; ;', metadata={'source': 'lista_test_2.csv', 'row': 12}),\n",
       " Document(page_content='REPORT;20;20: Shareholders have the possibility of receiving ROVI’s financial information automatically ;through an e-mail alert system.  Furthermore, the group provides regular, prompt and ;relevant information on the company, such as presentations and legal documents on ;economic and financial aspects and corporate governance, which may be consulted in the ;Investors and Shareholders section of the corporate website www.rovi.es.;Coinciding with its General Shareholders’ Meeting, ROVI prepares an Integrated Report ;in which it summarises the strategic lines of its work and the activities carried out in ;the preceding year. This document forms part of the Informe Reporta, prepared by the ;consulting company Deva, which rates the reports published by the companies listed on the ;General Index of the Madrid Stock Exchange (IGBM) in accordance with the quality of the ;information they provide. In the 2020 edition of Informe Reporta, ROVI was in 22nd place of ;this ranking, which is formed by 120 companies, maintaining the same position as it held in ;2019.; –Customers;ROVI has a query channel for information requests from both international partners and ;direct customers, patients and professionals: www.bemimed.com.;In the event of a complaint, the company opens an enquiry immediately in order to identify ;the cause and prevent any repetition. Furthermore, there is a contact telephone number and ;the e-mail rovi@rovi.es where queries and complaints may be made.; –Society and environment;As a catalyst in its socioeconomic surroundings and aware of the impact of its activity on ;the environment, ROVI is committed, as an integral part of its day-to-day activity, to the ;protection of the environment, as well as to improving the situation of society in general and ;the different geographical areas  all over the world where it is present with its product or ;plants.;The company’s environmental policy is based on commitments to continuing improvement ;of products and processes, while, at the same time, complying with both legal requirements ;and additional voluntary requirements. In relation to environmental queries, ROVI has a ;corporate procedure through which it manages communications (queries, complaints, etc.) ;related to the environment and occupational health and safety. On the corporate website ;(www.rovi.es), the quality, environmental and occupational health and safety certifications ;held by group companies are available to the public. ;Over recent years, the company has carried out intensive activity to support research and ;promote prevention and knowledge of certain diseases. ROVI allocates part of its resources ;to driving medical and healthcare knowledge forward through contributions to different ;projects and co-operation with higher-education entities, with which it also works to help ;young professionals enter the workplace through scholarships and training. ;27', metadata={'source': 'lista_test_2.csv', 'row': 25})]"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "similares"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "''"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "pregunta = '¿De qué empresa es este informe?'\n",
    "similares = recuperador.get_relevant_documents(pregunta)\n",
    "cadena.run(input_documents = similares, question = pregunta)  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "Could not load Llama model from path: ./data/models/gpt4all-7B/gpt4all-lora-quantized_new.bin",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mFileNotFoundError\u001b[0m                         Traceback (most recent call last)",
      "File \u001b[1;32mc:\\Users\\Faji\\anaconda3\\envs\\gdelt\\lib\\site-packages\\langchain\\embeddings\\llamacpp.py:76\u001b[0m, in \u001b[0;36mLlamaCppEmbeddings.validate_environment\u001b[1;34m(cls, values)\u001b[0m\n\u001b[0;32m     75\u001b[0m \u001b[39mtry\u001b[39;00m:\n\u001b[1;32m---> 76\u001b[0m     \u001b[39mfrom\u001b[39;00m \u001b[39mllama_cpp\u001b[39;00m \u001b[39mimport\u001b[39;00m Llama\n\u001b[0;32m     78\u001b[0m     values[\u001b[39m\"\u001b[39m\u001b[39mclient\u001b[39m\u001b[39m\"\u001b[39m] \u001b[39m=\u001b[39m Llama(\n\u001b[0;32m     79\u001b[0m         model_path\u001b[39m=\u001b[39mmodel_path,\n\u001b[0;32m     80\u001b[0m         n_ctx\u001b[39m=\u001b[39mn_ctx,\n\u001b[1;32m   (...)\u001b[0m\n\u001b[0;32m     89\u001b[0m         embedding\u001b[39m=\u001b[39m\u001b[39mTrue\u001b[39;00m,\n\u001b[0;32m     90\u001b[0m     )\n",
      "File \u001b[1;32mc:\\Users\\Faji\\anaconda3\\envs\\gdelt\\lib\\site-packages\\llama_cpp\\__init__.py:1\u001b[0m\n\u001b[1;32m----> 1\u001b[0m \u001b[39mfrom\u001b[39;00m \u001b[39m.\u001b[39;00m\u001b[39mllama_cpp\u001b[39;00m \u001b[39mimport\u001b[39;00m \u001b[39m*\u001b[39m\n\u001b[0;32m      2\u001b[0m \u001b[39mfrom\u001b[39;00m \u001b[39m.\u001b[39;00m\u001b[39mllama\u001b[39;00m \u001b[39mimport\u001b[39;00m \u001b[39m*\u001b[39m\n",
      "File \u001b[1;32mc:\\Users\\Faji\\anaconda3\\envs\\gdelt\\lib\\site-packages\\llama_cpp\\llama_cpp.py:46\u001b[0m\n\u001b[0;32m     45\u001b[0m \u001b[39m# Load the library\u001b[39;00m\n\u001b[1;32m---> 46\u001b[0m _lib \u001b[39m=\u001b[39m _load_shared_library(_lib_base_name)\n\u001b[0;32m     48\u001b[0m \u001b[39m# C types\u001b[39;00m\n",
      "File \u001b[1;32mc:\\Users\\Faji\\anaconda3\\envs\\gdelt\\lib\\site-packages\\llama_cpp\\llama_cpp.py:40\u001b[0m, in \u001b[0;36m_load_shared_library\u001b[1;34m(lib_base_name)\u001b[0m\n\u001b[0;32m     38\u001b[0m             \u001b[39mraise\u001b[39;00m \u001b[39mRuntimeError\u001b[39;00m(\u001b[39mf\u001b[39m\u001b[39m\"\u001b[39m\u001b[39mFailed to load shared library \u001b[39m\u001b[39m'\u001b[39m\u001b[39m{\u001b[39;00m_lib_path\u001b[39m}\u001b[39;00m\u001b[39m'\u001b[39m\u001b[39m: \u001b[39m\u001b[39m{\u001b[39;00me\u001b[39m}\u001b[39;00m\u001b[39m\"\u001b[39m)\n\u001b[1;32m---> 40\u001b[0m \u001b[39mraise\u001b[39;00m \u001b[39mFileNotFoundError\u001b[39;00m(\u001b[39mf\u001b[39m\u001b[39m\"\u001b[39m\u001b[39mShared library with base name \u001b[39m\u001b[39m'\u001b[39m\u001b[39m{\u001b[39;00mlib_base_name\u001b[39m}\u001b[39;00m\u001b[39m'\u001b[39m\u001b[39m not found\u001b[39m\u001b[39m\"\u001b[39m)\n",
      "\u001b[1;31mFileNotFoundError\u001b[0m: Shared library with base name 'llama' not found",
      "\nDuring handling of the above exception, another exception occurred:\n",
      "\u001b[1;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[5], line 2\u001b[0m\n\u001b[0;32m      1\u001b[0m \u001b[39mfrom\u001b[39;00m \u001b[39mlangchain\u001b[39;00m\u001b[39m.\u001b[39;00m\u001b[39membeddings\u001b[39;00m \u001b[39mimport\u001b[39;00m LlamaCppEmbeddings\n\u001b[1;32m----> 2\u001b[0m LlamaCppEmbeddings(model_path\u001b[39m=\u001b[39;49m\u001b[39m'\u001b[39;49m\u001b[39m./data/models/gpt4all-7B/gpt4all-lora-quantized_new.bin\u001b[39;49m\u001b[39m'\u001b[39;49m)\n",
      "File \u001b[1;32mc:\\Users\\Faji\\anaconda3\\envs\\gdelt\\lib\\site-packages\\pydantic\\main.py:339\u001b[0m, in \u001b[0;36mpydantic.main.BaseModel.__init__\u001b[1;34m()\u001b[0m\n",
      "File \u001b[1;32mc:\\Users\\Faji\\anaconda3\\envs\\gdelt\\lib\\site-packages\\pydantic\\main.py:1102\u001b[0m, in \u001b[0;36mpydantic.main.validate_model\u001b[1;34m()\u001b[0m\n",
      "File \u001b[1;32mc:\\Users\\Faji\\anaconda3\\envs\\gdelt\\lib\\site-packages\\langchain\\embeddings\\llamacpp.py:98\u001b[0m, in \u001b[0;36mLlamaCppEmbeddings.validate_environment\u001b[1;34m(cls, values)\u001b[0m\n\u001b[0;32m     92\u001b[0m     \u001b[39mraise\u001b[39;00m \u001b[39mModuleNotFoundError\u001b[39;00m(\n\u001b[0;32m     93\u001b[0m         \u001b[39m\"\u001b[39m\u001b[39mCould not import llama-cpp-python library. \u001b[39m\u001b[39m\"\u001b[39m\n\u001b[0;32m     94\u001b[0m         \u001b[39m\"\u001b[39m\u001b[39mPlease install the llama-cpp-python library to \u001b[39m\u001b[39m\"\u001b[39m\n\u001b[0;32m     95\u001b[0m         \u001b[39m\"\u001b[39m\u001b[39muse this embedding model: pip install llama-cpp-python\u001b[39m\u001b[39m\"\u001b[39m\n\u001b[0;32m     96\u001b[0m     )\n\u001b[0;32m     97\u001b[0m \u001b[39mexcept\u001b[39;00m \u001b[39mException\u001b[39;00m:\n\u001b[1;32m---> 98\u001b[0m     \u001b[39mraise\u001b[39;00m \u001b[39mNameError\u001b[39;00m(\u001b[39mf\u001b[39m\u001b[39m\"\u001b[39m\u001b[39mCould not load Llama model from path: \u001b[39m\u001b[39m{\u001b[39;00mmodel_path\u001b[39m}\u001b[39;00m\u001b[39m\"\u001b[39m)\n\u001b[0;32m    100\u001b[0m \u001b[39mreturn\u001b[39;00m values\n",
      "\u001b[1;31mNameError\u001b[0m: Could not load Llama model from path: ./data/models/gpt4all-7B/gpt4all-lora-quantized_new.bin"
     ]
    }
   ],
   "source": [
    "from langchain.embeddings import LlamaCppEmbeddings\n",
    "LlamaCppEmbeddings(model_path='./data/models/gpt4all-7B/gpt4all-lora-quantized_new.bin')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "gdelt",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.16"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
